Absara Cosmetics' hand sanitizer labeled 70% ethanol tested at 58%, leading to CGMP citations.
What happened
FDA detained and refused admission of the hand sanitizer at the U.S. border and laboratory-tested a batch. Testing found 58% v/v ethanol although the label said 70%. After an Oct. 16, 2020 teleconference, FDA said the firm's test methods and investigation were inadequate, and FDA placed all firm drugs on Import Alert 66-78 on Feb. 4, 2021.
What FDA found
The hand sanitizer labeled to contain 70% ethanol actually contained 58% v/v ethanol, so its strength was below its label.
FD&C Act section 501(c), 21 U.S.C. 351(c)FDA said the lower strength shows that quality assurance at the facility is not working under CGMP.
FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)The firm's test methods differed from USP methods without justification and lacked validation or equivalence documentation, an internal standard, system suitability, and had calculation errors.
21 CFR 211.160The firm's investigation into the subpotent batch was not adequately justified, did not establish the root cause, and did not review test methods, laboratory operations, or analytical results.
21 CFR 211.192
What FDA wants
FDA asks for a detailed follow-up investigation of the subpotency, a list of raw materials and suppliers, a reconciliation of all hand sanitizer batches shipped to the U.S., complete batch records, and the test methods and specifications used. The firm must respond in writing within 15 working days.
Who should pay attention
- U.S. distributors and retailers of imported hand sanitizer
- brands using Absara Cosmetics as a contract manufacturer
- quality teams managing supplier verification for OTC drugs
This is a summary. Read the original letter on fda.gov.